Because several genes and pathways have been shown by others to synergize with the Wnt-β-catenin pathway in HBL, it is likely that EGFR-ASAP1 signaling is another such pathway, which modulates Wnt-β-catenin signaling in HBL in a subset of affected children. The gene discussed is ASAP1; the disease is hepatoblastoma.